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1Highlights
GAs and iPLS improved errors of determined concentrations with Raman spectroscopy.
The whole non-linearity of the dataset can be removed by LWR, pPLS or SVM.
High non-linearity appears if a component of high Raman-activity occurs in samples.
Raman map was created with real concentration applying proper quantitative regression.
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4Abstract
This work demonstrates how nonlinearity in Raman spectrometry of pharmaceuticals can be 
handled and accurate quantification can be achieved by applying certain chemometric 
methods including variable selection. Such approach proved to be successful even if the 
component spectra are very similar or spectral intensities of the constituents are strongly 
different. The relevant examples are: blends of two crystalline forms of carvedilol (“CRYST-
PM” blend) and a three-component pharmaceutical model system (“PHARM-TM” blend). 
The widely used classical least squares regression (CLS) and partial least squares regression 
(PLS) quantification methods provided relatively poor root mean squared error of prediction 
(RMSEP) values: approximately 2-4% and 4-10% for CRYST-PM and PHARM-TM 
respectively. The residual plots of these models indicated the nonlinearity of the preprocessed 
data sets. More accurate quantitative results could be achieved with properly applied variable 
selection methods. It was observed that variable selection methods discarded the most 
intensive bands while less intensive ones were retained as the most informative spectral 
ranges. As a result not only the accuracy of concentration determination was enhanced, but 
the linearity of models was improved as well. This indicated that nonlinearity occurred 
especially at the intensive spectral bands. Other methods developed for handling nonlinearity 
were also capable of adapting to the spectral nature of both data sets. The RMSEP could be 
decreased this way to 1% in CRYST-PM and 3-6% in PHARM-TM. Raman maps with 
accurate real concentrations could be prepared this way. All quantitative models were 
compared by the non-parametric sum of ranking differences (SRD) method, which also 
proved that models based on variable selection or nonlinear methods provide better 
quantification.
Keywords: hyperspectral imaging; pharmaceutical analysis; chemometrics; multivariate 
regression; variable selection; nonlinear behavior
51. Introduction
Chemical imaging, including Raman mapping, has been a particularly rapidly emerging 
technique in analysis and characterization of various substances in the last decade. This 
method has several advantages over non-imaging spectroscopic techniques. Besides 
qualitative and quantitative characterization of ingredients in bulk materials, it can provide 
further information about spatial distribution of major and even minor (sometimes trace) 
components [1]. Many diverse issues have been already solved using chemical imaging in the 
field of life sciences and diagnostics [2,3], forensic sciences and counterfeiting [4,5], food 
analysis [6,7], plastics [8] and artworks [9]. In recent years, the application of this approach 
has sparked explosively growing interest particularly in the pharmaceutical industry [10,11]. 
Raman (or NIR) chemical imaging is greatly applicable for performing detailed analysis in 
various steps of manufacturing processes [12,13]. Researchers pay more and more attention to 
quantification, further highlighting the relevance of this topic.
There are many issues in which Raman spectroscopy and hyperspectral imaging has helped 
tackle serious challenges, such as identifying unexpected chemical substances or new 
polymorphs [14,15], investigating blend homogeneity [16], or testing polymorphic stability 
[17,18]. These qualitative studies reveal various types of information about the samples, 
allowing better understanding of pharmaceutical processes. However, the interest, regarding 
pharmaceutics, is mostly focusing on the complex view of the structure and the real 
quantification of component. Since FDA approved the guidance on Process Analytical 
Technology (PAT) [19], the significance of spectroscopic techniques has extremely grown 
thanks to their superior adaptability into continuous manufacturing processes [20-23]. 
Ongoing quality control can be achieved through accurate spectral evaluation, to which, 
however, the use of chemometrics is essential.
6Since a vibrational (such as Raman, IR or NIR) spectrum contains hundreds or thousands of 
wavenumbers of interest, it is a multivariate entity, which progresses to a further level of 
complexity when combined with hyperspectral imaging (which requires processing of even 
thousands of spectra within the same dataset). Numerous chemometric methods may serve the 
quantification efforts [10,24-26]. In the simplest cases univariate approaches using one 
selective wavenumber can provide useful results. However, in many cases a sufficiently 
selective band does not exist [10], in which case multivariate methods has to be used 
encompassing the whole spectral range or parts of it [27]. One of the most easily interpretable 
methods is the classical least squares (CLS). It can be adapted fast for simple spectrum 
characterization when the spectra of all components are known and spectrum of each 
compound can be generated from pure spectra using spectral contributions (as estimated 
concentrations). However, some interfering effects, such as spectral similarity of components 
or material interactions or nonlinear behavior, may occur making it necessary to use more 
sophisticated approaches. Some authors have reported successful application of widespread 
chemometric methods such as partial least squares regression (PLS) or principal component 
regression (PCR) [28-30]. These methods were successfully used in polymorphic studies, 
where the component spectra are only slightly different. PLS is especially preferred for 
quantification of selected polymorphs in a mixture. 
A large part of the spectral range is often non-informative in the quantitative evaluation. In 
such cases variable selection methods, such as interval partial least squares (iPLS) [31,32] or 
genetic algorithms (GA) [33-35], are promising candidates for treating the spectra and 
retaining only the sufficiently descriptive variables. In some cases, a certain degree of 
nonlinearity appears in the data, caused by interaction between components or due to spectral 
preprocessing. This phenomenon can be handled by polynomial partial least squares (pPLS) 
[36,37], locally weighted regression (LWR) [38,39] or support vector machine for regression 
7(SVR) [40,41]. pPLS works similarly to the conventional PLS regression, but it uses higher 
degree inner relations by determining polynomial functions between score values of 
dependent and independent variables called X-block scores and Y-block scores. LWR was 
applied based on PLS projection by fitting local PLS models to a specified range of adjacent 
observations. Applying SVR, the regression is carried out in a higher-dimensional feature 
space, in which the nonlinearity of the original input data can be handled properly. The 
construction of the suitable hyperplane is performed by a kernel function and regularized by 
several parameters (see Section 2.4.3.)
Although the conventional data analysis methods (CLS, PCR, PLS) proved to be successful in 
many applications, advances in chemical imaging and in pharmaceutical process-monitoring 
calls for novel chemometric methods [25,42]. Nevertheless up to now only few 
pharmaceutical related studies have demonstrated the advantageous use of aforementioned 
chemometric ways for variable selection and handling of nonlinearity. Support vector 
machine, for instance, has been proposed as a promising candidate [42] and used  in Raman 
[43] and UV [44] quantitative spectroscopic studies, iPLS was applied in determination of 
Vitamin B12 in pharmaceutical tablets [45] and in the quantification of ibuprofen-
nicotinamide co-crystals [46], while LWR has been used in a NIR quantitative analysis [47]. 
However, detailed comparative study demonstrating the relevance of the mentioned methods 
for quantitative determination of polymorph ratio and tablet composition based on Raman 
mapping has not published yet. Thus, the aim of this study is to evaluate the applicability of 
these tools in analysis of two model systems of pharmaceutical importance.
2. Materials and methods
2.1 Materials
8Two-component mixtures of crystalline polymorphs of carvedilol model drug (referred to as 
CRYST-PM) were studied. The commercial carvedilol product (EGIS Pharmaceuticals Plc., 
Budapest, Hungary) consisted of pure Form II polymorph. Form I was obtained by a solvent 
mediated polymorphic transition process. First, 25 g Form II was dissolved entirely in 120 mL 
ethyl-acetate (Merck, Germany) heating the solution until 77 °C. The solution then was 
cooled while 2.5 g of Form I polymorph was added as seed crystals. The recrystallization 
occurred at 50 °C in three hours [48]. Crystals were removed by filtration. After drying the 
product purity was verified by Raman mapping.
The three component pharmaceutical model system (PHARM-TM) contained imipramine 
(EGIS Pharmaceuticals Plc., Budapest, Hungary) as model drug and microcrystalline 
cellulose (FMC BioPolymer, Princeton, USA) and maize starch (Colorcon, West Point, USA) 
as excipients. Each component was sieved to ensure the same particle size range (50-100 µm), 
to avoid segregation.
2.2 Preparation of mixtures and tablets
Uniform binary mixtures were achieved by grinding and mixing carvedilol Form I and Form 
II in a mortar with pestle, creating nineteen blends with different mass ratios (see Table 1). 
The total weight of each mixture was 2.00 g and the measurements of the components were 
carried out on analytical balance (precision of 0.1 mg). As the precision of the weighted
quantity of the components were within 5 mg, there was no significant difference between the 
prepared actual and nominal concentrations. The mixtures were prepared right before the 
Raman measurements. Sufficient homogeneity was obtained by ten minutes of thorough 
homogenization, which was checked by collecting three Raman maps per mixtures (See 
Section 2.3.). As there were no differences in the spatial distribution of the Raman maps of 
the three samples, the homogeneity of the mixtures were deemed to be representative.
9PHARM-TM was prepared and homogenized in the same manner and then it was compressed 
into a flat tablet (Camilla ‘95 OL57; Manfredi, Torino, Italy). Before analyzing the tablet 
form was broken in half and the fracture surface was mapped. Fig. 1 represents the nineteen 
nominal compositions. Due to long measurement time (see Section 2.3), the representative 
sampling were not intended to achieve by repeated Raman mapping instead, the homogeneity 
of the measured samples was checked by macropixel analysis [49] (see details in 
supplementary material).
2.3 Raman mapping experiments
Raman spectra were collected using a Horiba Jobin-Yvon LabRAM system coupled with an 
Olympus 97 BX-40 optical microscope (Olympus Corporation, Tokyo, Japan). Raman 
mapping of CRYST-PM blends were carried out with an external 532 nm frequency-doubled 
Nd-YAG laser source, while the samples of PHARM-TM were illuminated by a 785 nm diode 
laser (TEC 510 type, Sacher Lasertechnik, Marburg, Germany). An objective of 10× 
magnification was used for optical imaging and spectrum acquisition. The laser beam is 
focused through the objective, and backscattered radiation is collected with the same 
objective, as usual in most confocal spectroscopic systems. The collected radiation is directed 
through an edge filter that removes the Rayleigh photons, then through a confocal hole and 
the entrance slit onto a grating monochromator that disperses the light before it reaches the 
CCD detector. 
The Raman maps of polymorphs were collected with a spectral range of 345-1790 cm-1. The 
acquisition time for one spectrum was 1 s and 3 spectra were averaged per pixel. 
Samples were investigated in 441 points by collecting a 21×21 pixel sized image with 50 µm 
step size. Each sample was mapped three times to ensure representativeness of the sampling.  
10
Mixtures of PHARM-TM were investigated in a spectral range of 458-1678 cm-1. Two spectra 
were accumulated using an acquisition time of 30 s in each spatial position. 13×13 pixels 
sized images (169 points) were collected with a step size of 50 µm.
2.4 Data analysis
Basic evaluation of the Raman maps (i.e. unfolding of the 3D data cube, basic preprocessing) 
were carried out using LabSpec 5.41 (Horiba Jobin Yvon, France). Chemometric analyses 
were performed using MATLAB 8.2. (MathWorks, USA) and PLS Toolbox 7.8.2. 
(Eigenvector Research, USA). Sum of ranking differences (SRD) method was carried out 
using a VBA macro in Excel 2010 (Microsoft, USA) made available by the developers 
(http://aki.ttk.mta.hu/srd/).
The spectrometric map was originally acquired in a 3-dimensional hypercube form (sized 
n × m × λ), which contained the spectral intensities. Two of the cube dimensions are the 
spatial coordinates, while the third corresponds to the wavelength channels. Before any 
chemometric analysis, the data had to be unfolded into a 2-dimensional matrix along to the 
coordinates in order to treat the data in the mentioned programs. Wavelength channels are in 
columns of the data matrix (in this case number of the channels is 1000) and each row 
contains a spectrum of a measured point.
Quantitative models were built by using the averaged spectra of the Raman maps. The sample 
sets were divided into calibration and validation sets as marked in Table 1 and Fig. 1. All 
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model building was conducted on calibration set, while the validation set was used to examine 
the predictive power of these models. On the calibration sets, contiguous blocks cross-
validation was also performed by leaving out one concentration level at a time. 
All Raman mapped spectra were preprocessed by baseline correction and normalization. 
Other preprocessing methods such as mean centering, autoscaling, multiplicative scatter 
correction (MSC) and standard normal variate (SNV) were also tested in various 
combinations. The combinations that provided the lowest RMSE value were applied for the 
final model building.
The goodness of fit, i.e. the performance of the model was evaluated by comparing the 
predicted and actual concentrations, using the two most widely used measures, namely the 
coefficients of determination (R2) and the root mean square errors (RMSE). The indicators of 
goodness were calculated for calibration (R2cal, RMSEC), prediction (R
2
pred, RMSEP) as well 
as cross-validation (R2cv, RMSECV).
R2 values come from the conventional analysis of variance in model fitting [50]. However, 
coefficient of determination was not in itself used to drive any decisions; it was used as a 
secondary metric to the RMSE values. The root mean square error (RMSE) was a simple 
measure to compare the calculated concentrations from the model and the “real” (actual or 
measured by other means) concentrations (see Equation 1).
(Eq. 1)
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N is the number of elements of the set, yi
(real)is the actual concentration in spectrum i. The 
yi
(calc) refers to the predicted concentration and may come from the calibration set (RMSEC), 
validation set (RMSEP) or the cross-validation iterations (RMSECV).
The comparison of prediction and cross-validation played an important role in the 
examination of overfitting. To test the predictive power of the models, in this study the 
RMSEP values of the validation set were compared with the RMSECV values. Inspecting the 
residual plots is an efficient way of revealing the nonlinearity of the models.
Sum of ranking differences [51,52], which is a non-parametric statistical process, was applied 
to compare the models. The objects (the quantitative models in this case) can be ordered and 
ranked based on a comparison to a reference (e.g. estimated concentrations are compared to 
actual concentrations in each pixel). The ranking differences are then summed. These SRDs 
are scaled to 0 to 100 percent, indicating the fully perfect match (0%) and the completely 
reversed ranking, respectively. Accordingly, the method having the lowest SRD is regarded as 
the best. By generating high number of random rankings, a Gaussian distribution is obtained 
to test whether the rankings of the examined methods differ significantly from the randomly 
generated rankings (see supplementary material).
2.4.1 Reference methods
Univariate regression and classical least squares (CLS) principal component regression (PCR) 
and partial least squares (PLS) models were used as reference models methods to estimate the 
concentrations in the mixtures. These methods are detailed in the literature [28-30].
2.4.2 Variable selection methods
Spectra with thousands of wavelength channels (variables) usually contain some non-
informative variables. Although PCR and PLS project data to lower dimensions, aiming to 
retain only the substantial information, in fact each latent variable created still takes all 
13
original variable into account, which reduces the predictive power of the model. To make 
models more accurate, non-informative regions should be completely removed before 
regression. For this purpose, two variable selection methods were tested. 
Interval PLS [31,32]: Interval PLS is based on a systematic search of the best combination of 
variables to reach a better estimation against PLS on the whole spectral range. First, the 
spectra are divided into variable windows, with a window size specified by the user. Utilizing 
variable windows enables us to select meaningful bands of the spectra instead of standalone 
wavenumbers. However, the application of wider windows can obstruct the entirely 
elimination of non-informative variables, while narrow windows could lead to overfitting. 
Hence, determining the appropriate window size is a substantial matter of optimization, which 
was carried out by minimizing the RMSECV values. The searching algorithm can run in two 
different modes. Applying forward selection mode, the initial step is a PLS model built with 
one variable window and RMSECV is calculated. In the next steps, variable windows are 
individually added and PLS models are built. Variable windows are added until the best 
subset of variable windows (resulting model with the lowest RMSECV) is found. Reverse 
mode operates in the opposite direction. The first PLS model is built by eliminating only one 
window from the spectra, then variable windows are excluded successively until the 
RMSECV of the PLS models cannot be reduced further. In this way, iPLS determine a subset 
of variables with which the goodness of PLS model is enhanced. Nevertheless, it has to be 
noted that being a stepwise method, iPLS tend to stuck in local minimum, hence it does not 
necessarily results the best subset.
PLS regression aided by Genetic algorithms (PLS-GA) [33-35]: Compared to the iPLS 
method, PLS-GA is suitable for finding the variable subsets resulting in the global minimum 
of RMSECV and then the best subset can be applied in a PLS regression. The searching 
algorithm operates on the analogy of natural selection. Sets of variable windows (genes) are 
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used to create regression models (individuals) which are compared to one another based on 
the RMSECV (the fitness function) values. These models form a “population”. The best half 
of the models is left in the population, while the rest are discarded. The remaining “survivor” 
genes are “crossed over” to fill up the population to its original size (while some mutation 
may occur as well), creating a new “generation” to next calculation. The algorithm stops 
when the required convergence criterion or the maximum number of generation is reached.
2.4.3 Regression methods for handling nonlinearity
Polynomial PLS (pPLS) [36,37]: PLS regression can be used for nonlinear curve fitting by 
using higher powers of scores. During the model building process the nonlinear/polynomial 
function has to be determined to describe the relationship in the inner model of PLS.
Locally weighted regression (LWR): [38,39] It is worth noting that LWR is a linear method 
locally. Nevertheless it can be used if data sets exhibit nonlinearity as it decomposes a single 
model in a series of local models [53]. Curve fitting with locally weighted regression method 
is carried out by considering only a defined number of adjacent points during the regression 
process. Adjacent points are also weighted LWR the distance from the given calibration point. 
The weight function and the number of adjacent points had to be determined by the user. The 
regression can be carried out either with the original variables or in the principal component 
space. 
Support vector regression (SVR) [40,41]: Support vector regression is a machine learning 
method that is based on the transformation of the nonlinear data matrix into a higher 
dimension space where the data points fit to a linear curve. The transformation is carried out 
by a kernel function. Gaussian radial basis function kernel was applied, which is referred as a 
type of nonlinear SVR [43,54]. The effectiveness of SVR depends on parameter (γ) which 
influences the “curliness” of the kernel. In order to fit the regression function, two other 
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parameters also had to be set. The margin of tolerance (ε) affects the number of points 
involved in curve fitting, as only the calibration points outside or on the margin (called 
support vectors) are actually taking part in the regression. The cost (C) value represents the 
penalty associated with errors larger than ε.
3. Results and discussion
The two selected model systems allowed us to study the quantification of pharmaceutical 
samples in various aspects. Carvedilol polymorph mixtures (CRYST-PM) made it possible to 
study the accuracy of the quantification of components with high spectral similarity (Fig. 2). 
This examination can be essential to convince us, for instance, about purity or long-term 
stability of polymorphic form of active pharmaceutical ingredient (API). Detection and 
quantification limits at low concentration are required to recognize the appearing impurities. 
For these reasons, data analysis was mainly carried out at low concentration levels.
Effective quantification of blends of an API and excipients (PHARM-TM model system) is 
also a significant issue during drug formulation steps or in quality control. Although the 
model system consisted of three components only, data evaluation was difficult due to the fact 
that the spectra of the selected two typical excipients were similar to each other (see Fig. 3). 
In addition, imipramine has much larger Raman activity than the excipients. Consequently, 
applying the necessary spectral preprocessing (e.g. normalization), leaded to nonlinearity in 
the spectral data (meaning that the peak intensities have a nonlinear correspondence to the 
actual concentrations). Our approach aimed at the development of an effective model that is 
suitable to quantify all components in these blends.
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3.1 Preprocessing
Before any chemometric analysis, it is required to preprocess the data. Baseline correction 
was needed to eliminate fluorescent background scattering. In CRYST-PM the same baseline 
was subtracted from all the measured spectra approaching it with a piecewise linear baseline 
attached to the assigned wavenumbers. However, in the PHARM-TM system, determining 
one piecewise linear function, which is appropriate for the correction of each spectrum is a 
cumbersome procedure due to the spectral and fluorescent differences of the components. For 
this reason the method of asymmetric least squares [55] was applied to fit a nonlinear 
baseline, which is defined by two parameters: the asymmetry parameter p, the value of which 
is ranging usually from 10-3 to 10-1, and the smoothness parameter λ, generally set 
exponentially in the range of 102 and 109. In this study, the baseline were tuned empirically to 
p=10-2 and λ= 105. 
In mapping studies, normalization is also commonly used to eliminate the intensity fluctuation 
caused by the error of focusing due to surface roughness. If this is not treated by some sort of 
normalization (bringing back each spectrum to the same scale) then all quantitative algorithms 
will be inherently affected by the goodness of the focusing in each pixel. However, spectral 
normalization, balancing the Raman-activity differences of the components, leads to loss of 
information and distorts quantification. Although it has some unwanted side effect of 
spreading out spectral differences on the entire spectrum this disadvantage is much smaller 
than the negative impact caused by the lack of normalization. As spectra of different 
polymorphs usually have similar Raman-activity, normalization constituted only slight 
interference in the CRYST-PM samples. In contrast, in the case of three component system 
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(PHARM-TM) normalization biased strongly the real contribution of imipramine (as the 
Raman intensities of the components were highly different). 
In addition to baseline correction and normalization, mean centering, autoscaling, 
multiplicative scatter correction (MSC) and standard normal variate (SNV) were also tested in 
various combinations in the case of each calibration method. The best combination was 
applied for each model; these can be seen in Table 2 and Table 3.
3.2 Reference methods
In order to understand the significance of using variable selection and methods handling the 
nonlinearity, first, we carried out the quantification studies in comparison with reference 
methods described in Section 2.4. Preliminary studies with univariate regression showed that 
the selectivity of the visually chosen wavelength (725.9 cm-1 and 753.1 cm-1 in the case of 
CRYST-PM and 1594 cm-1, 480 cm-1, 1096 cm-1 for PHARM-TM) influence significantly the 
accuracy of the quantification. In the case of both model systems the method resulted in 
quantification errors higher than 3% (Table 2-3).
Classical least squares (CLS) regression method with CRYST-PM did not yield any better 
results than univariate regression: RMSEs exceeded 3% and it was not able to discriminate 
between the adjacent concentration levels. The residual plot (difference of predicted and 
actual concentration) shows nonlinearity in the data (Fig. 7.a). In the case of PHARM-TM the 
CLS model compared to univariate regression provided better determination for each 
component, however the RMSE values still remained about 10%. The highest error was 
observed in PHARM-TM (Fig. 4), which can be explained by the fact that this is the case 
when normalization caused the greatest bias in the spectrum of the API. The residual plot of 
imipramine shows nonlinearity too (Fig. 4.c).
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Using principal component regression (PCR) and partial least squares (PLS) methods the 
main issue is the following: in order to avoid overfitting the number of principal 
components/latent variables (LVs) have to be determined cautiously. The optimization is 
carried out by the minimization of RMSECV, however, it is not sufficient to recognize 
overfitting. Our previous study [56] pointed out that overfitting is more effectively tackled 
when the search for the optimal LV numbers is not solely performed according to the 
minimum of RMSECV. It is also advised to keep in mind that the number of LVs should not 
greatly exceed the (known) number of components in the calibration samples. Considering all 
these factors, two latent variables were used in the PCR and PLS model of carvedilol system 
and this way the RMSE values were reduced to 2% (see Table 2). However, to analyze 
impurities in the samples (i.e. achieve better predictions for small concentration levels for 
each component), more accurate models are required. It also has to be mentioned that strong 
nonlinearity was observed related to the accuracy of estimations in the residual plots (Fig. 
7.b).
PHARM-TM was quantified by using 3 LVs. The PLS model with mean centering was 
capable of decreasing the RMSEs of imipramine by partially diminishing the bias induced by 
normalization. Nevertheless, the errors of determination were still rather high (about 6-8%) 
due to a certain degree of nonlinearity remaining, which had to be reduced.
3.3 Variable selection methods
When applying variable selection methods, it should be kept in mind that a band in the 
spectrum includes more than one variable; hence groups of adjacent variables (wavenumbers) 
should be treated together. This was set by using a pre-defined size of variable windows 
instead of single variables. Different window sizes were tested and the optimum was 
determined based on the RMSECV values. Interval PLS and PLS-GA methods resulted in the 
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best predictions for CRYST-PM when the window size was set to contain 25 variables (it 
equals approximately 36 cm-1 in this case). After the model construction, the RMSEP values 
were calculated. When window sizes of 10 or 5 were used, RMSEP exceeded RMSECV, 
indicating that narrow window sizes cause overfitting (see Fig. 5). It was found that there are 
more combinations of wavelength intervals which characterize the model system equally well 
(RMSE values equal in their first decimal); in other words, iPLS algorithm found different 
local minimums of RMSECV. 
Genetic algorithms aided PLS-GA method was performed applying RMSECV as the fitness 
function. The mutation rate, i.e. the probability of the mutation during the double cross-over 
was set to 0.5% and the population size of 64 was applied. The algorithm stopped when the 
convergence criterion of 50% or 200 generations were reached. These parameters were 
optimized empirically based on previous study [56], however it was found that they have 
much less impact on the RMSE values than the window size. The run of PLS-GA was 
monitored through diagrams (Fig. 6) showing the evolution of RMSECV values in the 
function of the number of applied variable windows in a particular generation (Fig. 6.a) as 
well as in the function of the generations (Fig. 6.b). Fig. 6.b depicts how the algorithm 
approaches a minimum value of RMSECV and Fig. 6.c presents that the number of variable 
windows is reduced by the end of the process. The final result of the variable selection is 
illustrated in Fig. 6.d, where the chosen variable windows of the last generation are depicted 
on the frequency of their occurrence. Consecutive runs and repeated analyses showed that 
certain variable windows were frequently selected. The PLS models built by these runs 
equally resulted in improved model goodness. No significant difference was identified 
between the repeated GA runs, thus only the results of one calculation is detailed in Table 2.
Additionally, it is important to note that the most intensive bands were discarded by all GA 
runs, which can be explained by the massively nonlinear or overlapping behavior of these 
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peaks. Hence this result is an important argument against the application of univariate 
methods, even if selective bands seem to be suitable to distinguish particular components. The 
iPLS and PLS-GA models of CRYST-PM provided error of determination of approximately 
1% with moderate level of nonlinearity (Fig. 7.c).
The use of variable selection methods led to positive effects in the PHARM-TM results as 
well. The variable selection affected the RMSEs of each component to a different extent, 
which made the comparison of the models more complex. Most of the selected variable 
windows included the peaks of imipramine, while the wide bands of the excipients were 
selected less frequently. Accordingly, the greatest improvement in the goodness of prediction 
was reached in the quantification of imipramine. The best iPLS and PLS-GA models provided 
quantification of each component with an error around 5% (see Table 3). If the accuracy of 
quantification of a particular component was improved individually in PHARM-TM the 
concentration estimation of the other two components tended to deteriorate. Comparing iPLS 
and GA-based algorithm we found no significant differences in the best possible accuracy. It 
always depends on the problem at hand to decide which model is required to work with (e.g.
if mapping one particular component was of interest, or the spatial distribution of all 
ingredients are of equal importance). In the present study, those models were considered as 
best, which served the optimum for all three components.
3.4 Methods for handling nonlinearity
In the residual plots of CRYST-PM, nonlinearity was still observed (Fig. 7.a-c), hence 
regression methods for handling nonlinearity were required to achieve even better fit. pPLS 
models were built by testing different degrees of a polynomial function of PLS scores. A 
model using the second power caused the lowest RMSECV, (Fig. 8) thus, this model was 
considered as optimum. The previously observed parabolic -nature of residuals (for linear 
21
models) were completely eliminated (Fig. 7.d). When building a PLS model with higher 
powers of scores the RMSECV increased to such an extreme extent that suggested the model 
to be overfitted. 
Locally weighted regression was applied in the principal component space (number of LVs 
set to two) with a tricubic weight function. In the optimization step the number of adjacent 
points had to be defined: i.e. how many consecutive observations should be considered in a 
local model? This number was appointed from 2 to 36 (the total number of calibration points) 
for LWR models to search the optimum. The lowest detected RMSECV in the regression 
model were found when approximately the half of the calibration points was set as adjacent as 
Fig. 9 shows. At 4 adjacent points another local minimum can be found. It is not unusual as 
three observations were applied per concentration level. The local models were improved 
significantly considering the fourth point. Fig. 9 also depicts that even if all points are 
included (as adjacent), lower error can be achieved by the LWR model than by the 
conventional linear PLS model. Comparing to the PLS-GA the performance of pPLS is 
similar in Table 2. In this case variable selection eliminated the nonlinearity almost perfectly, 
thus the application of nonlinear methods is not necessarily required. However, to find the 
best calibration model, it can be useful to test which method handle the nonlinearity better and 
provides better quantification.
Support vector regression (SVR) was carried out by transforming the data into a higher 
dimension space by a Gaussian kernel function. As SVR models can be easily overfitted, 
careful optimization was required. In the first step, the algorithm was allowed to optimize the 
three parameters (γ, C, ε) to find the minimum of RMSECV. This optimization determined 33 
support vectors (from the total number of 36), which indicates a “very curly” regression 
function and is thus most likely overfitted. Changing the value of ε, which in fact only slightly 
influenced the RMSECV, allowed us to reduce the number of support vectors to 7. As a result 
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of this manual optimization, a γ-C-ε combination was found that it obtained a low RMSECV 
by keeping the number of support vectors low (and thus the regression function smooth and 
reliable, corresponding to the principle of parsimony) and could be used for prediction 
(RMSEP was 1.13%) at the same time.
In the course of quantification of PHARM-TM, different degree of nonlinearity was observed 
(Fig. 4) in the residual plots of the different components. This made the application of the 
methods for handling nonlinearity more complicated. The nonlinear nature was the most 
significant in the case of imipramine, which is the consequence of the main factor that the 
spectrum of the API was the most biased by the normalization (as previously mentioned). 
During the application of methods for reducing nonlinearity the task is to find a function that 
characterizes the nonlinearity of each component at the same time. As LWR and SVR cannot 
be interpreted with more than one dependent variable at the same time (meaning that a 
separate model would have to be built for each component) these methods could not be used 
in that manner as the reference methods. For these reasons in the case of PHARM-TM, only 
pPLS is discussed in this study and is compared to the other methods.
Second power found to be optimal when pPLS with 3 latent variables and different degrees of 
polynomial functions were tested. This resulted in reduction of the nonlinearity and the errors 
of API determination decreased by one percent (RMSEP 2.93). However, this model 
improved the quantification of excipients only slightly (keeping the errors of determination 
around 6 %) when nonlinearity was not significant.
3.5 Comparison of the models 
The aforementioned comparisons after the model building process were based on the root 
mean square errors and on the coefficients of determination. A more advanced approach to 
compare the models is provided by the Sum of ranking differences (SRD) method [51,52]. In 
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this study the actual concentrations as well the means of concentrations estimated by the 
different models were selected as references. In this way, SRD proved to be able to indicate 
sensitively if a model was unable to discriminate correctly among the adjacent concentration 
levels due to inaccurate estimation. Hence the method was especially useful for the evaluation 
of the CRYST-PM’s models. SRD was not applied on the PHARM-TM results as the 
locations of investigated concentrations were so different from each other, that the use of SRD 
for the concentration values made no sense.
Fig. 10 shows the comparison of the sums of rankings. The SRD method provided a ranking 
of the models that indicated the overall power of the models. Fig. 10 clearly shows that the 
reference methods, including PCR and PLS, performed the worst in this context (these 
methods were the least able to distinguish between adjacent concentration levels). SRD 
evaluated the iPLS and pPLS models as much better models having low SRD values 
(independently of the used reference). The univariate method led to moderately low SRD 
exceeding the efficacy of some multivariate methods in this context. Consequently, the 
intensity of the peak of 753 cm-1 increases by raising Form I concentration but in highly 
nonlinear way. The result of SRD was validated by comparing the SRD values with Gaussian 
random ranking and leave-many-out cross validation was performed as well. (see 
supplementary material)
3.6 Models applied on Raman-maps
The most accurate models according to the different comparisons were further tested on such 
Raman maps which were not used for either model building or validation. During the model 
building process optimization was performed by the minimization of RMSECV. However, 
having been aware of the fact that RMSECV alone is not suitable to identify overfitting, 
extreme values of parameters was not accepted even if it could have result in lower 
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RMSECV. After the model construction, the relation of RMSECV and RMSEP values was 
monitored to check if the overfitting was avoided successfully. 
Quantifying new samples with known concentrations allowed us to investigate the true 
efficacy of a built model and confirm the successful elimination of overfitting. For this reason 
a Raman map with 101×101 pixels (5×5 mm area) from a sample with 5% carvedilol Form I 
and 95% Form II content was investigated. In the case of the PHARM-TM system, a sample
containing 50% maize starch, 25% imipramine and 25% MCC were Raman mapped in 49×49 
data points (2.4×2.4 mm area).
Prediction of the 5% overall carvedilol Form I content improved compared to the 
conventionally used CLS model by more advanced models. Concentration maps estimated by 
a reference and an advanced method were emphasized and visualized in Fig. 11. Fig. 11.a 
shows that CLS predicted 7.06 %, while LWR provided 5.26% according to Fig. 11.b. Largest 
improvement was observed in latter case. iPLS model provided 5.45%. Although PLS-GA 
model achieved accurate quantification according to the RMSEs it overestimated the overall 
Form I content more than PLS did on the large test map (5.87% with PLS-GA vs 5.76% with 
PLS) suggesting slight overfitting.
During the analysis of the PHARM-TM it was noticed that considerable differences appeared 
in the concentration maps of MCC and imipramine, while the prediction for maize starch was 
not affected strongly by the models. The models with variable selection predicted the actual 
concentration of imipramine outstandingly well but these were less accurate with the 
prediction of the excipients. 
The Raman maps shown in Fig. 11 represent, owing to the applied quantitative chemometric 
methods, real concentrations at each point instead of the so called “spectral concentrations” 
generally used in publications.
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4. Conclusions
Quantification of two-component polymorph mixtures and three-component blends of API 
and excipients was carried out by Raman chemical imaging combined with multivariate 
calibration methods, some of which applied the first time in this field. This work demonstrates 
how accurate quantitative determination can be achieved using regression for handling 
nonlinearity and variable selection procedures compared to the widely used CLS, PCR and 
PLS methods. 
With the aid of the proposed method Raman mapping can be used for determining the real 
quantitative composition of pharmaceutical samples. Furthermore, it enables us to analyze 
extreme low concentrations providing a powerful tool for contaminant analysis of drug 
polymorphs. 
It was found that a variable selection model or a model for eliminating nonlinearity improves 
significantly the analysis of a particular component having the most nonlinear features. 
Nevertheless, the quantification of other components can be improved with these models 
simultaneously. 
The quantitative models shown in this study can become an integral part of a continuous 
pharmaceutical manufacturing process such as controlled crystallization or a content 
uniformity test after tableting, in line with the concept of PAT. For this purpose further 
advanced spectroscopic techniques are needed to be implemented performing truly real-time 
control. For example, transmission Raman spectroscopy is a promising way for shortening 
exposure times, although spatial information is lost in that case. Alternatively, novel 
techniques able to replace the lengthy scanning procedure by simultaneous measurement of 
all points can be developed further [57-59].
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Table 1 CRYST-PM mass ratios and composition of calibration and validation sets
Sample Form I Form II
type of
set
Sample Form I Form II
type of 
set
CAR_1 0% 100% cal. CAR_11 70% 30% cal.
CAR_2 1% 99% cal. CAR_12 85% 15% cal.
CAR_3 2% 98% val. CAR_13 89% 11% val.
CAR_4 3% 97% cal. CAR_14 92% 8% cal.
CAR_5 5% 95% val. CAR_15 95% 5% val.
CAR_6 8% 92% cal. CAR_16 97% 3% cal.
CAR_7 11% 89% val. CAR_17 98% 2% val.
CAR_8 15% 85% cal. CAR_18 99% 1% cal.
CAR_9 30% 70% cal. CAR_19 100% 0% cal.
CAR_10 50% 50% val.
Table 2: Performance characteristics of quantitative models of CRYST-PM (bc: baseline 
correction. nm: normalization. mncn: mean centering. SNV: standard normal variate)
Univ. CLS PCR PLS iPLS PLS-GA pPLS LWR SVR
Preprocessing bc. nm bc. nm bc. nm. mncn. SNV
bc. nm.
mncn
bc. nm
bc.nm.
mncn.
SNV
RMSEC 3.20 3.48 1.82 1.68 1.14 1.01 1.06 0.89 1.16
RMSECV - - 4.00 2.16 1.30 1.18 1.67 1.74 1.54
RMSEP 3.16 3.63 1.88 1.91 1.20 1.19 1.24 1.38 1.13
R2cal 0.9941 0.9931 0.9981 0.9984 0.9993 0.9994 0.9994 0.9996 0.9992
R2cv - - 0.9912 0.9973 0.9990 0.9990 0.9985 0.9984 0.9987
R2pred 0.994 0.9921 0.9984 0.9983 0.9994 0.9994 0.9993 0.9992 0.9994
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Table 3: Performance characteristics of quantitative models of PHARM-TM 
Univ. CLS PCR PLS iPLS PLS-GA pPLS
RMSEC
Starch 9.36 6.82 6.03 6.09 4.87 5.62 6.00
Cellulose 60.02 5.76 5.83 5.47 4.67 3.00 3.73
API 11.68 10.04 6.33 5.67 3.46 3.95 5.97
RMSECV
Starch - 8.50 7.77 8.10 6.95 7.69 8.60
Cellulose - 7.11 8.01 7.69 6.54 4.79 6.47
API - 12.60 8.71 8.37 5.61 7.39 7.67
RMSEP
Starch 7.38 6.17 6.48 6.53 5.28 5.37 6.01
Cellulose 18.98 6.71 6.20 5.39 3.95 4.23 6.34
API 15.10 12.51 4.28 3.90 4.37 2.50 2.93
R2cal
Starch 0.9275 0.9601 0.9674 0.9669 0.9788 0.9718 0.9670
Cellulose 0.2871 0.9712 0.9696 0.9733 0.9805 0.9919 0.9875
API 0.8908 0.9174 0.9641 0.9712 0.9893 0.9861 0.9681
R2cv
Starch - 0.9406 0.9463 0.9417 0.9570 0.9473 0.933
Cellulose - 0.9573 0.9431 0.9477 0.9617 0.9795 0.962
API - 0.8753 0.9322 0.9374 0.9720 0.9512 0.9473
R2pred
Starch 0.8178 0.8934 0.8690 0.8648 0.9319 0.8764 0.882
Cellulose 0.3646 0.6952 0.6898 0.7421 0.8601 0.8434 0.713
API 0.9509 0.9000 0.9000 0.9438 0.9602 0.9654 0.9271
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Figure captions
Fig. 1 Ternary diagram of the mixtures of PHARM-TM (filled circles indicate validation 
samples)
Fig. 2 Raman spectra of the two kinds of polymorphs of carvedilol 
Fig. 3 Raman spectra of imipramine active ingredients and the two kinds of excipients 
(microcrystalline cellulose /MCC/ and maize starch)
Fig. 4 Residuals in CLS modelling of PHARM-TM for a) maize starch, b) microcrystalline 
cellulose and c) imipramine
Fig. 5 Model errors achieved with different variable window sizes (number of adjacent 
variables which is treated together) in a) genetic algorithm b) interval PLS for the data set of 
CRYST-PM
Fig. 6 Monitoring plots of a PLS-GA run (CRYST-PM): a) information about the fitness and 
the used window number in the single models, b) converging the values of the best (brownish 
line) and average fitness of the constructed models (blue line) along the generations, c) the 
average window numbers in models, d) the frequencies of each window in the final models
Fig. 7 Trends of residuals for calibration and validation points in CRYST-PM using a) CLS, 
b) PLS, c) iPLS and d) pPLS chemometric methods (arbitrarily fitted red lines demonstrate 
nonlinearity)
Fig. 8 Dependence of root mean square errors of calibration, cross-validation and prediction 
on the polynomial degree of scores in pPLS model of CRYST-PM
Fig. 9 Change of root mean square errors in LWR model depending on the number of local 
points considered
Fig. 10 Percentages of SRD for best models of the examined methods in the case of CRYST-
PM applying actual concentrations as reference (0% indicates the same ranking as the 
reference ranking; 100% belongs to the fully opposite ranking
Fig. 11 Distribution maps of carvedilol mixture containing 5% of Form I quantified by a) CLS 
(7.06%) and b) LWR(5.26%). 
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